Polymarket puts 67% odds on AI-developed skin cancer vaccine winning FDA approval

Polymarket · x · 2026-10-13

Polymarket's contract on an AI-developed skin cancer vaccine receiving FDA approval is currently priced at 67%. The replies turn it into a joke: Palantir's CTO quips that many AI researchers have taken up smoking to demonstrate their confidence that AI will cure cancer.

Original post →

More from Fun

Fun channel →